SuperworthBioCardia market cap BCDA
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $13.9M
- Highest close in our data
- $906.6M
- Jun 2017
BioCardia is worth $13.9M at the close on Oct 23, 2026, at $0.92 a share.
That is up 73% over the last year and down 90% over five years.
Its highest close in our data was $906.6M in Jun 2017.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $13.9M | $9.4M | $17.7M | +3% |
| 2025 | $13.5M | $6.7M | $15.4M | +20% |
| 2024 | $11.3M | $4.8M | $14M | −21% |
| 2023 | $14.4M | $13M | $169.2M | −87% |
| 2022 | $111.9M | $72.9M | $123.5M | +14% |
| 2021 | $98.2M | $88.6M | $246.9M | −24% |
| 2020 | $129M | $47M | $142.8M | +69% |
| 2019 | $76.4M | $49.4M | $192.9M | −32% |
| 2018 | $112.5M | $112.5M | $338.2M | −58% |
| 2017 | $269.5M | $269.5M | $906.6M | −64% |
| 2016 | $747.9M | $48.4M | $747.9M | +1253% |
| 2015 | $55.3M | $41.5M | $89.8M | −33% |
| 2014 | $82.9M | $56.3M | $96.7M | +33% |
| 2013 | $62.2M | $41.5M | $110.6M | +55% |
| 2012 | $40.1M | $40.1M | $69.1M | −17% |
| 2011 | $48.4M | $41.5M | $76M | n/a |
Against its peers
Companies in Healthcare nearest BioCardia's size, closest first, today.
| Company | Market cap |
|---|---|
| BCDABioCardia | $13.9M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on BioCardia
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.